title: We do not agree with the 2012 statement’s recommendation of long-duration HT use that may last until the age of 51 years (or longer if needed for symptom management).
authors.forename: Ruey-Jien
authors.initials: RJ
authors.lastname: Chen
authors.forename: Chia-Hung
authors.initials: CH
authors.lastname: Chou
authors.forename: Ting-Chen
authors.initials: TC
authors.lastname: Chang
mesh_terms: D005260:Female; D020249:Hormone Replacement Therapy / Q000009:adverse effects*; D006801:Humans